Mortality risk prediction in scleroderma-related interstitial lung disease: the SADL model

J Morisset, E Vittinghoff, BM Elicker, X Hu, S Le, JH Ryu… - Chest, 2017 - Elsevier
Background Interstitial lung disease (ILD) is an important cause of morbidity and mortality in
patients with scleroderma (Scl). Risk prediction and prognostication in patients with Scl-ILD …

The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease

AU Wells - European respiratory review, 2010 - Eur Respiratory Soc
Bronchoalveolar lavage (BAL) has been used in diagnostic and prognostic evaluation in
diffuse parenchymal lung disease for three decades and has a central role in the diagnosis …

Interstitial lung disease in systemic sclerosis

AU Wells - La Presse Médicale, 2014 - Elsevier
Based on international collaborative data, interstitial lung disease is now the most frequent
cause of death in systemic sclerosis (SSc), having supplanted renal crisis in that regard …

Interstitial lung disease in systemic sclerosis: focus on early detection and intervention

A Fischer, NM Patel, ER Volkmann - Open access rheumatology …, 2019 - Taylor & Francis
Systemic sclerosis (SSc) is a progressive and often devastating disease characterized by
autoimmune dysfunction, vasculopathy, and fibrosis. Interstitial lung disease (ILD) is …

Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent

R Invernizzi, J Barnett, B Rawal, A Nair… - European …, 2020 - Eur Respiratory Soc
Increasing bacterial burden in the lower airways of patients with idiopathic pulmonary
fibrosis confers an increased risk of disease progression and mortality. However, it remains …

Biomarkers in connective tissue disease-associated interstitial lung disease

F Bonella, U Costabel - Seminars in respiratory and critical care …, 2014 - thieme-connect.com
This article reviews major biomarkers in serum and bronchoalveolar lavage fluid (BALF) with
respect to their diagnostic and prognostic value in connective tissue disease–associated …

[HTML][HTML] Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis

R Hesselstrand, M Wildt, G Bozovic… - Respiratory …, 2013 - Elsevier
Objectives Decision on treatment of systemic sclerosis (SSc) related interstitial lung disease
(ILD) largely relies on the findings on high resolution computed tomography (HRCT) and …

Diagnostic criteria, severity classification and guidelines of systemic sclerosis

Y Asano, M Jinnin, Y Kawaguchi… - The Journal of …, 2018 - Wiley Online Library
Several effective drugs have been identified for the treatment of systemic sclerosis (SS c).
However, in advanced cases, not only their effectiveness is reduced but they may be also …

Clinical role of bronchoalveolar lavage in dermatomyositis-associated interstitial lung disease

L He, Y Ge, S Li, K Huang, X Liu, F Chen, S Li… - …, 2022 - academic.oup.com
Objective To investigate the role of bronchoalveolar lavage (BAL) in DM-associated
interstitial lung disease (ILD). Methods We retrospectively reviewed the medical records of …

[HTML][HTML] The role of bronchoalveolar lavage in systemic sclerosis interstitial lung disease: A systematic literature review

M Orlandi, LA Meliante, A Damiani, L Tofani, C Bruni… - Pharmaceuticals, 2022 - mdpi.com
The role of Bronchoalveolar Lavage (BAL) in the evaluation of systemic sclerosis (SSc)
interstitial lung disease (ILD) is still controversial. The aim of this systematic literature review …